Agreed, the lack of detail is very disappointing and the correlations are, I suspect, based on nothing more than joining up the dots. Given the large differences between closely spaced holes it's highly unlikely that these linear mineralisation features they have interpreted actually exist, at least not in that pattern.
The results are also nothing to get excited about. 17 holes of which only about 4 showed any decent mineralisation, and two of those appear to be redrills of historic holes (6 and 22). It's a pity as some of the results are pretty decent, good grades and shallow, but they are just not consistent enough to be exciting.
The next batch of results will be the interesting ones as they test the extensions at depth and also the IP anomalies. I bought in a while ago for Citadel and unfortunately haven't seen anything to sell me on Minyari yet.
- Forums
- ASX - By Stock
- AZY
- Ann: Minyari Phase 1 Drilling Update No. 3-AZY.AX
Ann: Minyari Phase 1 Drilling Update No. 3-AZY.AX, page-12
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AZY (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $51.81M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $87.49K | 7.534M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 20884956 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 11814202 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 20884956 | 0.011 |
54 | 20852853 | 0.010 |
33 | 13809155 | 0.009 |
18 | 8352820 | 0.008 |
4 | 2250000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 11814202 | 13 |
0.013 | 11067216 | 8 |
0.014 | 7141789 | 10 |
0.015 | 4568929 | 9 |
0.016 | 4415631 | 10 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AZY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online